This document summarizes surveillance data from Afghanistan's Disease Early Warning System (DEWS) between 2007-2012. It describes trends in priority diseases like acute respiratory infections (ARI), diarrhea, malaria, and measles. Key findings include that ARI cases show a cyclical pattern peaking in winter. The top ten provinces for various diseases are identified. For example, in 2012 the top provinces for pneumonia cases were Kabul, Nangarhar, Kandahar, Herat, and Balkh. The data aims to inform Ministry of Public Health decision-making.
TV INDUSTRY REPORT gives the overall picture of advertising on TV during the period Jan to Dec’12. It covers top advertisers, categories and brands and their % share in total advertising in terms of minutes. The report also focuses on share of TV channels, share of each genre and ad-spend split over the time slots. The report also compares % advertising in minutes done by various advertisers in 2012 vs. their share in 2011.
SOURCE: A JOINT RESEARCH STUDY OF PAS AND MEDIABANK PAKISTAN
Kharfen: DC HIV Public-Private Partnershipshealthhiv
Michael Kharfen
Bureau Chief, Partnerships, Capacity Building, Community Outreach
DC Department of Health
HIV/AIDS, Hepatitis, STD and TB Administration
A JOINT RESEARCH STUDY OF PAS AND MEDIABANK PAKISTAN
TV MONTHLY INDUSTRY REPORT gives the overall picture of advertising on TV during the month of October 13. It covers top advertisers, categories and brands and their % share in total advertising in terms of minutes. The report also focuses on share of TV channels, share of each genre and ad-spend split over the time slots. The report also compares % advertising in minutes done by various advertisers on YOY basis.
Assessing the Costs of Medication-Assisted Treatment for HIV Prevention in Ge...Irma Kirtadze M.D.
This study assesses the unit costs of MAT provision in Georgia from the perspective of the two service providers in-country—the Ministry of Labor, Health, and Social Affairs (MOLHSA) and the Global Fund to Fight AIDS, Tuberculosis, and Malaria (GFATM). Both MOLHSA and GFATM-funded sites offer MAT in multiple facilities throughout urban and rural Georgia. Treatment protocols and personnel requirements are centrally mandated, thus allowing for little variation per patient characteristics. While service delivery tends to be comparable across MOLHSA and GFATM sites, there is one significant difference—the ministry requires that MAT clients pay for services while GFATM offers free services. The analysis found that a majority of HIV-positive patients are enrolled in the GFATM MAT program.
The study compared average unit costs between two years (2009 and 2010) and found a minimal increase. Unit costs increased only slightly at MOLHSA facilities from 229 GEL ($133 ) per month to 236 GEL ($137) per month. At GFATM sites, the monthly per patient cost of MAT rose slightly between 2009 and 2010 from 217 GEL ($126) to 229 GEL ($133). Further, data analysis revealed that GFATM programs are only slightly less expensive than at MOLHSA facilities. An important caveat—unit cost calculations for the MOLHSA sites include patient contributions that amount to 150 GEL ($87) per month for each patient. In the case of both providers, direct costs of MAT provision far exceed indirect costs. Three inputs—personnel, drugs/medical supplies, and utilities—account for a major portion of costs associated with running MAT programs in Georgia. The most significant budget item in both MOLSHA and GFATM programs is the cost of personnel (salaries of clinical and support staff).
TV INDUSTRY REPORT gives the overall picture of advertising on TV during the period Jan to Dec’12. It covers top advertisers, categories and brands and their % share in total advertising in terms of minutes. The report also focuses on share of TV channels, share of each genre and ad-spend split over the time slots. The report also compares % advertising in minutes done by various advertisers in 2012 vs. their share in 2011.
SOURCE: A JOINT RESEARCH STUDY OF PAS AND MEDIABANK PAKISTAN
Kharfen: DC HIV Public-Private Partnershipshealthhiv
Michael Kharfen
Bureau Chief, Partnerships, Capacity Building, Community Outreach
DC Department of Health
HIV/AIDS, Hepatitis, STD and TB Administration
A JOINT RESEARCH STUDY OF PAS AND MEDIABANK PAKISTAN
TV MONTHLY INDUSTRY REPORT gives the overall picture of advertising on TV during the month of October 13. It covers top advertisers, categories and brands and their % share in total advertising in terms of minutes. The report also focuses on share of TV channels, share of each genre and ad-spend split over the time slots. The report also compares % advertising in minutes done by various advertisers on YOY basis.
Assessing the Costs of Medication-Assisted Treatment for HIV Prevention in Ge...Irma Kirtadze M.D.
This study assesses the unit costs of MAT provision in Georgia from the perspective of the two service providers in-country—the Ministry of Labor, Health, and Social Affairs (MOLHSA) and the Global Fund to Fight AIDS, Tuberculosis, and Malaria (GFATM). Both MOLHSA and GFATM-funded sites offer MAT in multiple facilities throughout urban and rural Georgia. Treatment protocols and personnel requirements are centrally mandated, thus allowing for little variation per patient characteristics. While service delivery tends to be comparable across MOLHSA and GFATM sites, there is one significant difference—the ministry requires that MAT clients pay for services while GFATM offers free services. The analysis found that a majority of HIV-positive patients are enrolled in the GFATM MAT program.
The study compared average unit costs between two years (2009 and 2010) and found a minimal increase. Unit costs increased only slightly at MOLHSA facilities from 229 GEL ($133 ) per month to 236 GEL ($137) per month. At GFATM sites, the monthly per patient cost of MAT rose slightly between 2009 and 2010 from 217 GEL ($126) to 229 GEL ($133). Further, data analysis revealed that GFATM programs are only slightly less expensive than at MOLHSA facilities. An important caveat—unit cost calculations for the MOLHSA sites include patient contributions that amount to 150 GEL ($87) per month for each patient. In the case of both providers, direct costs of MAT provision far exceed indirect costs. Three inputs—personnel, drugs/medical supplies, and utilities—account for a major portion of costs associated with running MAT programs in Georgia. The most significant budget item in both MOLSHA and GFATM programs is the cost of personnel (salaries of clinical and support staff).
Similar to Surveillance dews Afghanistan_14_jan2013 (20)
Ebola progress preparedness in AfghanistanIslam Saeed
Status of Ebola Preparedness based on WHO checklist. Dr. Islam Saeed, Director for Surveillance/DEWS in ANPHI-MoPH is part of Ebola Control Task Force for developing and implementation of Ebola Action Plan
Overview of International Health Regulaiton - IHR 2005, AfghanistanIslam Saeed
International Health Regulation and its implementation in Afghanistan was prepared by Dr. islam Saeed, Director for Surveillance/DEWS in MoPH Afghanistan
Epidermiologic pattern of viral hepatitis in afghanistanIslam Saeed
Epidemiology of Viral Hepatitis in Afghanistan. The presentation is prepared by Dr. Islam Saeed, Director for Surveillance/DEWS at Afghan National Public Health Institute (ANPHI), MoPH
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
1. Islamic Republic of Afghanistan
Ministry of Public Health
2013 Health Results Conference
January 13th and 14th 2013 – Kabul
SESSION: 2nd Day, Session 05
Surveillance/DEWS Data
Analysis and Results– 2007-2012
Presenter: Dr. Khwaja Mir Islam Saeed
MD (KMU), MSc-HPM (AKU), FELTP (NIH-ISB)
Director Surveillance/DEWS, ANPHI, MoPH
2. Surveillance/DEWS Directorate is a vital department of ANPHI
involved in routine reporting of priority diseases and outbreak
investigations
It is National Focal Point (NFP) for International Health
Regulations (IHR2005)
In Afghanistan, DEWS was first established in mid-December
2006, with technical support of WHO and financial support of
USAID
DEWS is a sentinel site based surveillance system for weekly
reporting of infectious diseases morbidity and mortality
While daily reporting system for injuries and seasonal diseases
are done by through Codan Radio system
3. Surveillance/ DEWS
International Central Office MOPH and
Agencies NGOS
CER CWR NR NER WR SR ER SER
55 SS in 4 49 SS 5 37SS in 4 41 SS in 4
Provinces Provinces Provinces Provinces
30 SS in 4 43 SS in 4
Provinces Provinces 41 SS in 5 34SS in 4
Provinces Provinces
Daily Surveillance for seasonal diseases and injuries from 34 provinces
4.
5. To describe the pattern of morbidity and
mortality due to priority diseases and
explain burden of outbreaks in
Afghanistan
To provide evidence for MoPH and
partners to take informed decisions
To encourage and improve data use and
culture of action based on information
6. Study Design: Analysis of Surveillance database
including routine reports, outbreak and lab reports
Sampling: All weekly, daily and outbreaks reports (line
lists) with lab data 2007-2012
Disease Under surveillance: 16 priority diseases
including ARI, Diarrheal Diseases, Meningitis/Severely ill
child, Acute Viral Hepatitis, Vaccine Preventable
diseases, Malaria, Typhoid Fever, Hemorrhagic Fever,
Pregnancy related deaths
Data Management: Paper and computer based using
forms, Ms Word, Excel and Access
Analysis and Dissemination: Descriptive analysis in
term of person, place and time
8. Cyclical trend of ARI ( Cough & Cold and Pneumonia)
as percentage of total clients 2007-2012
35.0% C&C
Pneumonia
Linear (C&C)
30.0% Linear (C&C)
25.0%
20.0%
15.0%
10.0%
5.0%
0.0%
Jan
Jan
Jan
Jan
Jan
Jan
Jul
Jul
Jul
Jul
Jul
Jul
Mar
Mar
May
Sep
Mar
May
Sep
Mar
May
Sep
May
Sep
Mar
Sep
Mar
May
Sep
May
Nov
Nov
Nov
Nov
Nov
Nov
2007 2008 2009 2010 2011 2012
9. Cyclical trend of ARI and ADD as percentage of total
clients 2007-2012
ADD ARI
40.0%
35.0%
30.0%
25.0%
20.0%
15.0%
10.0%
5.0%
0.0%
Jan
Jan
Jan
Jan
Jan
Jan
Sep
Sep
Jul
Jul
Jul
May
Sep
May
Sep
May
Sep
Jul
Jul
May
Sep
Jul
May
May
Mar
Nov
Mar
Nov
Mar
Nov
Mar
Nov
Mar
Nov
Mar
Nov
2007 2008 2009 2010 2011 2012
10. Cyclical trend of malaria and typhoid fever as
percentage of total clients 2007-2012
3.0%
Malaria
Typhoid F.
Linear (Malaria)
2.5%
2.0%
1.5%
1.0%
0.5%
0.0%
Jan
Jan
Jan
Jan
Jan
Jan
May
May
May
May
May
May
Mar
Jul
Sep
Mar
Jul
Sep
Mar
Jul
Sep
Mar
Jul
Sep
Mar
Jul
Sep
Mar
Jul
Sep
Nov
Nov
Nov
Nov
Nov
Nov
2007 2008 2009 2010 2011 2012
11. Top ten provinces with Pneumonia cases as
percentage of total clients, 2012
10%
9%
8%
7%
6%
5%
9%
4% 8%
7%
3%
5%
5% 5% 4% 4% 4%
2% 4% 4% 4% 4%
1%
0%
12. Top ten provinces with percentage of Diarrheal
Diseases from total clients, 2012
18%
16%
16% 16%
16%
15%
14% 15%
14%
14% 13% 13% 13%
12% 12%
12% 12%
10%
8%
6%
4%
2%
0%
13. Top ten provinces with percentage of Malaria cases
from total clients, 2012
2.50%
2.15%
2.00%
1.97% 1.95%
1.50%
1.34%
1.00% 1.04% 1.03%
0.89% 0.88%
0.81%
0.50%
0.50% 0.47% 0.46% 0.45%
0.00%
14. Top ten provinces with percentage of Acute viral
hepatitis cases from total clients, 2012
3000
2500
2498
2227
2000
1500
1000
500 516
440
368
319
261 260
192 178 131
0
15. Top ten provinces with percentage of Measles cases
from total clients, 2012
3500
3000
2500
2000
1500
1000
500
0
16. Top ten districts with percentage of ARI ( cough &
cold and Pneumonia) cases from total clients, 2012
Chapa Dara
Paghman
Kharwar
Dur Baba
Jabalussaraj
Fayzabad
Dara-I-Pech
Hisa-I- Awali Bihsud
Qarabagh
Muqur
Azra
Kohistan
0% 10% 20% 30% 40% 50% 60% 70%
17. Top ten districts with percentage of Acute Watery
Diarrheal cases from total clients, 2012
Dawlat Shah
Shahidi Hassas
Nawa-I- Barak Zayi
Dahana-I- Ghuri
LalPur
Dand Wa Patan
Bala Buluk
Arghandab
Kohistan
Jabalussaraj
Dawlatabad
Muqur
0% 10% 20% 30% 40% 50%
18. Top ten districts with number of Measles cases from
total clients, 2012
Maydan Shahr
Saydabad
Shinwar
Lashkar Gah
Kunduz
Khogyani
Jaji
Mihtarlam
Khost(Matun)
Mazari Sharif
Kabul
Jalalabad
0 500 1000 1500 2000 2500 3000
19. Top ten districts with percentage of Malaria cases
from total clients, 2012
Narang (Taragn -o-Badil)
Jaji
Qarghayi
Bar Kunar
Sarobi
Dawlat Shah
Dila
Maywand
Chawki
Nari
LalPur
Dand Wa Patan
0.0% 2.0% 4.0% 6.0% 8.0% 10.0% 12.0%
20. Weekly trend of ARI (pneumonia) by age groups in
2012
18000
16000
14000
5 Years & over
<5 Years
12000
10000
8000
6000
4000
2000
0
21. Weekly trend of diarrheal diseases by age groups in
2012
35000
30000
25000
20000
15000
10000
5000
0
<5 Years 5 Years & over
22. Weekly trend of ARI Measles cases by age groups in
2012
<5 Years 5 Years & over
400
350
300
250
200
150
100
50
0
23. Weekly trend of Typhoid fever by age groups in 2012
<5 Years 5 Years & over
2000
1800
1600
1400
1200
1000
800
600
400
200
0
W1
W5
W3
W7
W9
W13
W27
W31
W21
W23
W25
W37
W39
W29
W33
W35
W17
W11
W15
W43
W19
W47
W41
W45
24. Case Fatality Rate (CFR) Meningitis/SIC, 2007-2012
14.0
12.0
Case Fatality Rate(%)
10.0
8.0
6.0
4.0
2.0
0.0
Oct
Apr
Apr
Oct
Oct
Oct
Oct
Oct
Apr
Apr
Apr
Apr
Jan
Jan
Jan
Jan
Jan
Jan
Jul
Jul
Jul
Jul
Jul
Jul
2007 2008 2009 2010 2011 2012
25. Cyclical trend of Case Fatality Rate (CFR)
Pneumonia and Diarrheal Diseases, 2007-2012
0.9 0.25
0.8
Diarrheal Diseases CFR
0.7 0.20
Pneumonia CFR
0.6
0.15
0.5
0.4
0.10
0.3
0.2 0.05
0.1
0.0 0.00
Jan
Apr
Jul
Jan
Apr
Jul
Jan
Apr
Jul
Jan
Apr
Jul
Jan
Apr
Jul
Jan
Apr
Jul
Oct
Oct
Oct
Oct
Oct
Oct
2007 2008 2009 2010 2011 2012
ADD-CFR Pn-CFR
32. Sustainability of Surveillance system
White area in some provinces
Poor coordination among stakeholders
Turn-over of trained staff
Less clear role and responsibilities of different
partners
Lab limitation for infections and toxicology
IHR (2005) implementation as a legal requirement
Use of data
Dispersion and duplications of surveillance systems
Implementation of Influenza surveillance System
Security concern
33. Financial support of current successful/DEWS
surveillance system for future years
Expansion of BPHS coverage to white areas
Development and strengthening of coordination
Clear-cut role and responsibilities for
stakeholders
Motivation and maintaining of staff
Strengthening Lab support of surveillance
System
Supporting IHR-2005 implementations
Encouragement and promotion of data use
Establishment of Integrating Disease
Surveillance System (IDSR)
34. Figure-1: Proposed model-1: IDSR information flow Figure 2: Proposed model-II: Information flow
APHI – Surveillance APHI – Surveillance
National Level National Level
unit unit
CDs I I
monthly D D
(IDSR) R R
S S
Provincial APHI-Provincial APHI-Provincial
HIMS surveillance focal point Provincial Level surveillance focal point Provincial Level
manager
CDs I I I
monthly D D D
H (IDSR) R R R
M S S S
I M W
W I
S K N K I
D L L
L D
Y
R Y Y R
S
S
Health facility level N
Health facility level N
(Forms now in use: - IDSR-wkly, Tb, EPI, Polio & HMIS ) O
(Forms now in Use: - DEWS-wkly, Tb, EPI, Polio & HMIS ) O
T
T
I
N I
F N
O F
I O
T I
A T
I A
B I
F B
L F
I L
E I
A E
A
B
B
L
L
E
E
Community level
(Teams currently:- DEWS, Tb*, EPI, Malaria, Polio & HMIS )
Community level
(Teams currently:- DEWS, Tb, EPI, Malaria, Polio & HMIS )
*TB is not notifiable, but suspected cases detected are referred to the health facility (HF) *TB is not notifiable, but suspected cases detected are referred to the health facility